Literature DB >> 2973770

Circulating levels of sialic acid and glycosaminoglycans: a diagnostic test for ankylosing spondylitis.

A K Susheela1, T K Das, J S Khurana, A Jayaswal, P K Dave.   

Abstract

The circulating levels of sialic acid (N-acetylneuraminic acid) and glycosaminoglycans (GAGs) were measured in 69 patients with spinal disorders of orthopaedic interest (ankylosing spondylitis 17, osteofluorosis 6, idiopathic backache 10, osteoarthrosis 16, osteoporosis 20). The serum GAG levels showed no statistically significant change from control values in the five disorders investigated in the present study. Although osteoporosis and osteoarthrosis showed a decrease in serum sialic acid (SA) levels, the mean ratio (SA/GAG) demonstrated no change from control values. Idiopathic backache showed no difference in any of the parameters studied when compared with control values. Ankylosing spondylitis and osteofluorosis had a remarkable similarity in their clinical and radiological features, but a divergent mean value of ratio was noted. The mean ratio of both the conditions also showed a statistically significant difference from the control value. This suggests that the SA/GAG ratio can be used as a diagnostic test in ankylosing spondylitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973770      PMCID: PMC1003612          DOI: 10.1136/ard.47.10.833

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  The effect of inflammation of the hexuronate-containing polysaccharides of human plasma.

Authors:  G P KERBY
Journal:  J Clin Invest       Date:  1958-07       Impact factor: 14.808

2.  Plasma polysaccharide fraction containing uronic acid, in normal subjects and in patients with rheumatoid arthritis.

Authors:  J BADIN; M SCHUBERT; M VOURAS
Journal:  J Clin Invest       Date:  1955-08       Impact factor: 14.808

3.  Isolation and partial characterization of a glycoprotein from bovine cortical bone.

Authors:  B A Ashton; J T Triffitt; G M Herring
Journal:  Eur J Biochem       Date:  1974-06-15

4.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

5.  The quantitative measurement of Alcian Blue-glycosaminoglycan complexes.

Authors:  P Whiteman
Journal:  Biochem J       Date:  1973-02       Impact factor: 3.857

6.  Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.

Authors:  K M Sanders; A Hertzman; M R Escobar; B H Littman
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

7.  Plasma disappearance of rabbit alpha2HS-glycoprotein and its uptake by bone tissue.

Authors:  J T Triffitt; M E Owen; B A Ashton; J M Wilson
Journal:  Calcif Tissue Res       Date:  1978-12-08

8.  Mineral and collagen-binding proteins of fetal calf bone.

Authors:  J D Termine; A B Belcourt; K M Conn; H K Kleinman
Journal:  J Biol Chem       Date:  1981-10-25       Impact factor: 5.157

9.  Serum sialic acid levels in health and disease.

Authors:  A CARTER; N H MARTIN
Journal:  J Clin Pathol       Date:  1962-01       Impact factor: 3.411

10.  Haematology and biochemistry of ankylosing spondylitis.

Authors:  M J Kendall; D S Lawrence; G R Shuttleworth; A G Whitfield
Journal:  Br Med J       Date:  1973-04-28
View more
  2 in total

1.  Evaluation of mandibular bone mineral density using the dual-energy X-ray absorptiometry technique in edentulous subjects living in an endemic fluorosis region.

Authors:  U S Buyukkaplan; M U Guldag
Journal:  Dentomaxillofac Radiol       Date:  2012-01-12       Impact factor: 2.419

2.  A comparative assessment of clinical parameters, sialic acid, and glycosaminoglycans levels in periodontitis patients with and without dental fluorosis: A clinical and biochemical study.

Authors:  Prasad Sakthidharan Aswin; Kharidi Laxman Vandana
Journal:  J Indian Soc Periodontol       Date:  2020-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.